
Answer a few questions
Complete a short online consultation. No waiting rooms or queues.
from
£99.99(£25.00 per dose)


†SURMOUNT-1, 72-week study of adults with obesity using Mounjaro (tirzepatide 15mg). Individual results vary.
UK-licensed treatments that support healthy, sustainable habits.
†SURMOUNT-1, 72-week study of adults with obesity using Mounjaro (tirzepatide 15mg). Individual results vary.
*STEP UP, 72-week study of adults with obesity using Wegovy (semaglutide 7.2mg). Individual results vary.

Everything you need to feel informed and confident on your GLP-1 journey.
Explore Guide
Complete a short online consultation. No waiting rooms or queues.

Our qualified clinicians review your information and recommend treatment if it’s right for you.

If prescribed, your treatment will arrive directly to you in discreet packaging.
“The thing I like most is the aftercare. I get really helpful emails with tips and advice. After week one I’m 6lb down, so let’s see where it takes me on my weight loss journey.”
“Products are very effective. I’ve lost weight already in just 14 days so happy. Would recommend this company highly. In fact I’ve already introduced 3 people to MedExpress.”
“I am one week into treatment and feeling good — less cravings and fuller for longer in between meals. The website is really informative and ordering a straightforward process.”
“I am having a good experience. No side effects presently. I love the feeling of not feeling hungry, it’s very calming for me. I am enjoying the journey so far.”
“Professional, quick to respond, quick delivery and the product has made me feel the most confident I have felt in years.”

Dr. Bryony Henderson is Medical Director for MedExpress UK, bringing extensive experience in clinical operations, governance and digital health. She has previously held roles dedicated to delivering safe, scalable care across well-known brands. She is a recognised clinical voice contributing to award-winning campaigns, publishing on health inequalities, and appearing across national media. Here, Bryony leads clinical governance and quality, supporting the delivery of safe, innovative and accessible healthcare.

Adedayo Titiloye is Superintendent Pharmacist responsible for the safe and compliant delivery of pharmacy services across MedExpress. He brings experience across community pharmacy and regional operations, including leadership roles within one of the UK’s largest independent pharmacy groups. Here, Ade focuses on building high-performing teams, improving processes and ensuring pharmacy services deliver safe, effective care at scale.

Dr. Carla Rodrigues is Head of Medical Operations at MedExpress, having previously held leadership roles in primary care networks and across well-known healthcare organisations, and has led scientific society groups in the field of sexual medicine. She has also completed training with MIT, Harvard and INSEAD. At HeliosX, Carla leads medical operations in the UK, overseeing the delivery of safe care pathways and upholding high standards in prescribing and clinical governance.

Dr. Kavir Matharu is a GP Lead at MedExpress, with 10 years’ experience across a range of healthcare settings. She is a practising GP with a background in complex healthcare consulting, having worked on high-level strategic and operational challenges within the health system. She was also selected for a leadership fellowship with the National Medical Director at NHS England. Kavir has a strong interest in healthcare leadership and system improvement, with a focus on high-quality, sustainable care.

Dr. Daryl Perera is a GP Lead at MedExpress, with experience across NHS primary care, urgent care and private practice. He has extensive experience in digital healthcare and clinical leadership, and oversees clinical governance and patient safety across our digital health services. His work spans urgent care and preventative medicine, with particular interests in men’s health, obesity management, and sport and exercise medicine. Daryl has worked across a range of NHS and private healthcare organisations and previously held a GP Director role.

Head of Medical Affairs
BSc (Hons), MSc, PhD
Dr. Sophie Dix is Head of Medical Affairs at MedExpress and a behavioural neuroscientist with over 25 years’ experience across the pharmaceutical industry, charity sector and health technology. Her work has focused on understanding how to manage and treat conditions affecting both mind and body, bringing together scientific insight with real-world care. Sophie is passionate about evidence and ensuring people have access to the right treatment at the right time.

Medical Writer
BSc (Hons), MSc, PhD
Dr. Zoe Lees is a Medical Writer at MedExpress, specialising in clear, evidence-based health communications. She completed her postgraduate research at the University of Glasgow, focusing on metabolic complications of pregnancy and the role of adipose tissue function. Zoe brings a strong scientific foundation to her work and is committed to delivering content that is both accurate and accessible, grounded in robust research.

Dr. Adam Abbs is Medical Director, International at MedExpress responsible for expanding the company into new markets. He has extensive experience in asynchronous and video consultations, technology-enabled remote examinations and home biomarker testing, with a particular interest in educating both patients and doctors. Adam is a published author and is licensed to practice medicine in the UK and across the EU, and is registered in Canada.

Liyya Patel is Deputy Chief Pharmacist at MedExpress UK, with over 10 years’ experience supporting the organisation’s growth and development. She is responsible for ensuring pharmacy services are safe, compliant and meet all regulatory standards, playing a key role in maintaining high-quality clinical care. Liyya previously worked in high-volume community pharmacy settings in Central London and is a qualified pharmacist and independent prescriber.

Dr. Olivia de Rougemont is a GP Lead at MedExpress with over 12 years’ experience across the NHS and private sectors. She has extensive experience in digital and in-person care, with a particular interest in women’s health, preventative medicine, and delivering patient-centred support that feels clear and accessible. Olivia also leads and mentors GPs, and brings a global perspective shaped by her experience working across different healthcare systems.






“Mounjaro has changed my life. I am finally eating to fuel my body. Emotional binge eating is no longer a part of my life. MedExpress has been a fantastic company to deal with and I can’t recommend them enough. Thank you for helping me get my life back!”
Kirsten D.
Lost 3st 10lbs (23kg) with MedExpress
This customer received compensation for sharing their experience.

Yes, switching medications is a normal and common occurrence — it’s something medical professionals do regularly for conditions like high blood pressure or high cholesterol, whether it’s to reduce side effects or lower costs. We’ll work with you to find the treatment that’s right for your needs, budget and goals.
Read our guide to switching
Both Wegovy (semaglutide 7.2mg) and Mounjaro (tirzepatide 15mg) are highly effective for long-term weight loss, but they work slightly differently and may affect people differently.
In 72 weeks, people taking Wegovy 7.2mg in a clinical study lost an average of 20.7% of their body weight when taken as directed. This means that someone who weighs 100kg may lose 20.7kg on average in 72 weeks (1 year, 5 months).*
In 72 weeks, people taking Mounjaro 15mg in a clinical study lost an average of 22.5% of their body weight when taken as directed. This means that someone who weighs 100kg may lose 22.5kg on average in 72 weeks (1 year, 5 months).**
These are examples only. It is not a prediction of individual results.
Both can be excellent options. The right choice comes down to your health needs, goals, lifestyle and how your body responds to treatment. Our medical team will help you find what works best for you.
*STEP UP, 72-week study of adults with obesity using Wegovy (semaglutide 7.2mg). Individual results vary.
**SURMOUNT-1, 72-week study of adults with obesity using Mounjaro (tirzepatide 15mg). Individual results vary.
Wegovy and Mounjaro work in similar ways, so they can cause similar side effects. If you did well on Mounjaro, this can help your clinician choose a safe starting dose of Wegovy. However, it doesn’t mean your experience will be exactly the same.
Common side effects include nausea, vomiting, diarrhoea, constipation, and stomach pain. Some people may also feel tired or get headaches. These side effects are usually mild and often improve over time. They can sometimes feel worse if you're dehydrated or not getting enough nutritious food.
Our clinical team will create a plan that’s tailored to you. Our focus is on keeping you safe, reducing side effects, and helping you switch to Wegovy as smoothly as possible.
If you want tips on managing side effects, visit our Weight Loss Health Guide
Wegovy is now significantly less expensive per pen. It's also the first GLP-1 licensed for heart health benefits, is suitable for use with oral contraception, and tends to have fewer injection site reactions.
Learn more about how treatments compare
Simply start a free online consultation, answering some quick questions to check your eligibility.
You'll then see recommended treatments for you to choose from.
After checkout you'll be prompted to upload some quick photos to confirm your identity.
Your order will then be delivered quickly and discreetly, directly to your home.
Weight loss treatments are suitable for people with a BMI over 30. For individuals with weight related health concerns, they may be eligible with a BMI over 25. These related concerns include high blood pressure, diabetes, heart disease and raised cholesterol.
No, at MedExpress you can reorder your treatment as you need it. There's no ongoing contract or hidden fees, and you're always in control.